Literature DB >> 16088488

Reprocessing the bronchoscope: the challenges.

Majid M Mughal1, Omar A Minai, Daniel A Culver, Atul C Mehta.   

Abstract

Spread of infection through the flexible bronchoscope is underrecognized and underreported. Prevention of bronchoscopy-induced infection requires increased vigilance by the physician, assiduous implementation of reprocessing protocols, and closer collaboration between bronchoscopy personnel, infection control practitioners, and instrument manufacturers. Patient safety depends on adequate disinfection of bronchoscopes and accessories used, as well as proper training of bronchoscopists, nurses, and ancillary staff. It is important to recognize that microbial transmission may occur via any part of instruments or anything in contact with the instruments including cleaning solutions, automated washers, and rinsing water. Numerous surveys have suggested poor adherence to published preventive guidelines. To address the challenges of reprocessing bronchoscopes, all users must comply with guidelines for cleaning and disinfection and each procedure should be performed with a clean, disinfected bronchoscope.

Entities:  

Year:  2004        PMID: 16088488     DOI: 10.1055/s-2004-832717

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  3 in total

1.  The Cost of Flexible Bronchoscopes: A Systematic Review and Meta-analysis.

Authors:  Carina Østervig Andersen; Helena Travis; Emilie Dehlholm-Lambertsen; Rasmus Russell; Emmelie Ploug Jørgensen
Journal:  Pharmacoecon Open       Date:  2022-08-22

2.  Early Assessment of the Likely Cost Effectiveness of Single-Use Flexible Video Bronchoscopes.

Authors:  Christoffer Lilja Terjesen; Julia Kovaleva; Lars Ehlers
Journal:  Pharmacoecon Open       Date:  2017-06

3.  A systematic review and cost effectiveness analysis of reusable vs. single-use flexible bronchoscopes.

Authors:  J M Mouritsen; L Ehlers; J Kovaleva; I Ahmad; K El-Boghdadly
Journal:  Anaesthesia       Date:  2019-11-08       Impact factor: 6.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.